Literature DB >> 2655671

Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.

R P Barrett1, C Feinstein, W T Hole.   

Abstract

The effects of naloxone hydrochloride (Narcan) and naltrexone hydrochloride (Trexan) on the pervasive self-injury of a 12-year-old autistic and mentally retarded girl were examined. Using separate multiple schedule (A1/B/B') and withdrawal (A-B-A1B-A1) single-subject experimental designs, we investigated the effects of both opiate antagonists in serial fashion under double-blind, placebo-controlled conditions. Results of the two studies showed that self-injury increased during the naloxone trial, whereas a decrease to near zero rates of self-injury was observed following treatment with naltrexone. The differential effect produced by the two drugs was discussed in terms of drug half-life and the operant conditioning theory of extinction. Follow-up data showing near zero rates of self-injury for 22 months following the conclusion of active treatment with naltrexone indicated that the intervention produced a durable result.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2655671

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  11 in total

1.  Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management.

Authors:  P G Williams; A Allard; L Sears; N Dalrymple; A S Bloom
Journal:  J Autism Dev Disord       Date:  2001-02

Review 2.  Advances in the pharmacological treatment of pathological gambling.

Authors:  Jon E Grant; Suck Won Kim; Marc N Potenza
Journal:  J Gambl Stud       Date:  2003

Review 3.  Types of psychiatric treatment. Drug treatment.

Authors:  M Prendergast
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

4.  Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.

Authors:  R Knabe; P Schulz; J Richard
Journal:  J Autism Dev Disord       Date:  1990-12

Review 5.  Clinical safety of 1500 mg oral naltrexone overdose.

Authors:  Albert Stuart Reece
Journal:  BMJ Case Rep       Date:  2010-09-07

6.  Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.

Authors:  J Panksepp; P Lensing
Journal:  J Autism Dev Disord       Date:  1991-06

Review 7.  Emerging themes in the functional analysis of problem behavior.

Authors:  E G Carr
Journal:  J Appl Behav Anal       Date:  1994

Review 8.  Opiate antagonists in children and adolescents.

Authors:  N Chabane; M Leboyer; M C Mouren-Simeoni
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 9.  Management of Self-injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview.

Authors:  Ashley Sabus; James Feinstein; Patrick Romani; Edward Goldson; Allison Blackmer
Journal:  Pharmacotherapy       Date:  2019-03-27       Impact factor: 4.705

10.  A case report of naltrexone treatment of self-injury and social withdrawal in autism.

Authors:  A S Walters; R P Barrett; C Feinstein; A Mercurio; W T Hole
Journal:  J Autism Dev Disord       Date:  1990-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.